Last reviewed · How we verify

NCT03369288

Assessing Cement-bone Incorporation and Adjacent Segment Degeneration Following Cement Augmentation; an MRI-PET Follow-up

Status unknown NA Last updated 30 October 2018
What this trial tests

NA trial testing PET MRI in Vertebral Fracture in 30 participants. Status unknown.

Timeline
5 December 2017
Primary endpoint
28 June 2019
28 November 2019

Quick facts

Lead sponsorUniversity of Zurich
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment30
Start date5 December 2017
Primary completion28 June 2019
Estimated completion28 November 2019
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

Adults 18 to 75, any sex, with Vertebral Fracture or Cement Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

3-year PET-MRI follow-up after vertebral balloon kyphoplasty aiming to investigate cement incorporation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PET MRI

Trials testing the same drug.

Other recruiting trials for Vertebral Fracture

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03369288.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing